A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

University of Alabama, Birmingham, Alabama, United States

Mayo Clinic_Arizona, Phoenix, Arizona, United States

Mayo Clinic_Jacksonville, Jacksonville, Florida, United States

Baptist Health Miami Cancer Institute, Miami, Florida, United States

Washington University School of Medicine, Bay Saint Louis, Mississippi, United States

Memorial Sloan-Kettering Cancer Center, New York, New York, United States

Mayo Clinic_Rochester, Rochester, New York, United States

Duke University, Durham, North Carolina, United States

UT MD Anderson Cancer Center, Houston, Texas, United States

UT Health San Antonio Mays Cancer Center, San Antonio, Texas, United States

Inova Center for Personalized Health, Fairfax, Virginia, United States

UW Carbone Cancer Center, Madison, Wisconsin, United States